Healthcare

Biopharmaceutical firm Ocugen has achieved a significant clinical development goal just two days before its annual financial report. Company leadership...

For the first time in ten years, UnitedHealth Group is forecasting a drop in revenue, marking a significant inflection point...

NRx Pharmaceuticals is bolstering its executive team with a strategic hire aimed at accelerating the development of novel neuroplastic treatments....

The coming year represents a critical juncture for Viking Therapeutics, a biotechnology firm whose clinical pipeline is drawing significant investor...

Following a strategic realignment, IntelGenx is now channeling its efforts toward advancing its product pipeline and expanding manufacturing capabilities. The...

Axsome Therapeutics is embarking on a significant commercial and regulatory push. The biopharmaceutical company aims to solidify its position in...

A significant legal challenge has been resolved in favor of Abbott Laboratories. This week, a U.S. federal court issued a...

Investor confidence in Johnson & Johnson is strengthening, fueled by a significant regulatory milestone that adds momentum to the stock's...

Eli Lilly has provided a more definitive timeline for one of its most anticipated pipeline assets. During a presentation at...

In a strategic move during a period of intense focus on profitability in the health insurance sector, UnitedHealth Group has...